Savara (SVRA) EBITDA Margin (2013 - 2020)
Savara (SVRA) reported EBITDA Margin of 1305200.0% for Q4 2020, down 30470.1% quarter-over-quarter from 4269.53% in Q3 2020.
Savara (SVRA) EBITDA Margin (2013 - 2020) Analysis & Trends
Savara (SVRA) has 5 years of EBITDA Margin data on file, last reported at 1305200.0% in Q4 2020.
- EBITDA Margin for Q4 2020 came in at 1305200.0%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was 4187300.0% (changed N/A YoY), and the FY2020 annual result was 18932.3%, changed N/A from the prior year.
- EBITDA Margin eased to 1305200.0% in Q4 2020 per SVRA's latest filing, from 4269.53% in the prior quarter.
- Over five years, EBITDA Margin peaked at 11332.98% in Q2 2017 and troughed at 1305200.0% in Q4 2020.
- A 3-year average of 218584.98% and a median of 4704.45% in 2020 frame the typical range for EBITDA Margin.
- On a YoY basis, EBITDA Margin climbed as much as 3938283 bps in 2016 and fell as far as 3938283 bps in 2016.
- A 3-year view of EBITDA Margin shows it stood at 1149.5% in 2016, then soared by 1086 bps to 11332.98% in 2017, then tumbled by 11617 bps to 1305200.0% in 2020.
- Business Quant data shows SVRA's EBITDA Margin at 1305200.0% in Q4 2020, 4269.53% in Q3 2020, and 11332.98% in Q2 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Savara | 1.33 Bn | 1.33 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -1,305,200.00% |
| Sep 30, 2020 | -4,269.53% |
| Jun 30, 2017 | 11,332.98% |
| Mar 31, 2017 | -5,139.36% |
| Dec 31, 2016 | -1,149.50% |
| Sep 30, 2016 | -7,084.44% |
| Dec 31, 2015 | 38,233.33% |
| Jun 30, 2013 | -973.14% |
| Mar 31, 2013 | -1,405.78% |